in order to investigate the pharmacological specificity of the opiate aversive effects to peripheral opiate receptor subtypes , drug naive rats were administered various subcutaneous or intraperitoneal dose of the specific kappa receptor agonist u50,488 ( 0.005-16 mg/kg ) and run in a place conditioning paradigm .
C0034801
opiate receptor
C0064239
kappa